MedTrace Logo

Prevention of Spinal Induced Shivering During CS

NCT02588547 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2017-11-17

No results posted yet for this study

Summary

This study compares the efficacy of two different doses of intravenous (IV) granisetron on the prevention of postspinal shivering during cesarean section, in comparison with placebo.

Conditions

  • Spinal Induced Shivering

Interventions

DRUG

Granisetron

IV granisetron 1 mg before spinal anethesia

DRUG

Granisetron

IV granisetron 0.7 mg before spinal anethesia

DRUG

Sodium chloride

IV 2 ml 0.9 sodium chloride before spinal anethesia

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Seham M Moeen, MD · Assiut Univerisity

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02588547 on ClinicalTrials.gov